New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Lee Enterprises, Incorporated (NYSE:LEE), Arca Biopharma Inc (NASDAQ:ABIO), Clean Diesel Technologies, Inc (NASDAQ:CDTI), Oclaro, Inc (NASDAQ:OCLR)
Lee Enterprises, Incorporated (NYSE:LEE) showed a volume of 1.69 million shares by the end of last trade whereas the average volume of the stock remained 303,879.00 shares. The stock opened the session at $4.20 but then moved to $4.35. At that price, the stock showed a positive performance of 5.33%. Lee Enterprises, Incorporated provides local news, information and advertising in midsize markets, with 47 daily newspapers and a joint interest in four others, nearly 300 weekly newspapers and specialty publications in 23 states. The Company owns Pulitzer Inc. (Pulitzer). Pulitzer newspaper operations include St. Louis, Missouri, where its subsidiary, St. Louis Post-Dispatch LLC (PD LLC), publishes the St. Louis Post-Dispatch, the daily newspaper serving the greater St. Louis metropolitan area, and a range of specialty publications, and supports its related digital products. St.
Will LEE Continue To Move Higher? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) opened the session at $1.78 and closed the session at $1.80. The stock showed a positive performance of 3.45% in previous trading session. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA's lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF). The Company has collaborated with LabCorp to develop the Gencaro Test, a companion test for the genetic markers that may predict clinical response to Gencaro. ARCA's product candidate is Gencaro (bucindolol hydrochloride),
For How Long ABIO will fight for Profitability? Read This Trend Analysis report
Clean Diesel Technologies, Inc (NASDAQ:CDTI) opened the session at $1.62 and closed the session at $2.05. The stock showed a positive performance of 29.75% in previous trading session. The beta of the stock remained 2.18. Clean Diesel Technologies, Inc. is a global manufacturer and distributor of heavy duty diesels and light duty vehicle emissions control systems and products to automakers and retrofitters. The Company operates in two segments: Heavy Duty Diesel Systems division and Catalyst division. The Company's Heavy Duty Diesel Systems division specializes in the design and manufacture of verified exhaust emissions control solutions. Its Catalyst division produces catalyst formulations to reduce emissions from gasoline,
Why Should Investors Buy CDTI After The Recent Gain? Just Go Here and Find Out
Oclaro, Inc (NASDAQ:OCLR) the stock advanced 4.63% and finished the session at $2.71. Traded with volume of 1.63 million shares in the prior session and the average volume of the stock remained 928,555.00 shares. The beta of the stock remained 3.84. Oclaro, Inc. is a provider of optical communications and laser components, modules and subsystems for a range of markets, including telecommunications (telecom), industrial, scientific, consumer electronics and medical. The Company’s product offerings include tunable laser, lithium niobate external modulators, pump laser chips, thin film filters, and amplifiers. The Company is a supplier of optical network technology to telecom equipment companies worldwide.
Will OCLR Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)